Evidence map›Paper›PMID 37313117›Full record

ArticleThe journal of physical chemistry. C, Nanomaterials and interfaces2023

Universal Strategy for Reversing Aging and Defects in Graphene Oxide for Highly Conductive Graphene Aerogels.

Prabhat Kumar, Martin Šilhavík, Zahid Ali Zafar, Jiří Červenka

Abstract read
In one paragraph

Article in The journal of physical chemistry. C, Nanomaterials and interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prabhat KumarDepartment of Thin Films and Nanostructures, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, Prague 162 00, Czech Republic.ORCID https://orcid.org/0000-0001-5383-949X
Martin ŠilhavíkDepartment of Thin Films and Nanostructures, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, Prague 162 00, Czech Republic.ORCID https://orcid.org/0000-0003-3763-742X
Zahid Ali ZafarDepartment of Thin Films and Nanostructures, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, Prague 162 00, Czech Republic.
Jiří ČervenkaDepartment of Thin Films and Nanostructures, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, Prague 162 00, Czech Republic.ORCID https://orcid.org/0000-0002-1873-2475

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of highly stable, defect-free, and electrically conducting 3D graphene structures from graphene oxide precursors is challenging. This is because graphene oxide is a metastable material whose structure and chemistry evolve due to aging. Aging changes the relative composition of oxygen functional groups attached to the graphene oxide and negatively impacts the fabrication and properties of reduced graphene oxide. Here, we report a universal strategy to reverse the aging of graphene oxide precursors using oxygen plasma treatment. This treatment decreases the size of graphene oxide flakes and restores negative zeta potential and suspension stability in water, enabling the fabrication of compact and mechanically stable graphene aerogels using hydrothermal synthesis. Moreover, we employ high-temperature annealing to remove oxygen-containing functionalities and repair the lattice defects in reduced graphene oxide. This method allows obtaining highly electrically conducting graphene aerogels with electrical conductivity of 390 S/m and low defect density. The role of carboxyl, hydroxyl, epoxide, and ketonic oxygen species is thoroughly investigated using X-ray photoelectron and Raman spectroscopies. Our study provides unique insight into the chemical transformations occurring during the aging and thermal reduction of graphene oxide from room temperature up to 2700 °C.

Identifiers

PMID37313117
PMCPMC10258840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.